BIOMAT Database Logo BIOMAT Database Logo

Immuno reactive insulin responses to glycemic stimulus in maturity onset diabetics effect of severity and body weight. 1978

M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Insulin secretion, carbohydrate tolerance, fat metabolism and body weight in maturity onset diabetics requiring various methods of therapy.
April 1978, Endokrinologie,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Insulin sensitivity and vascular disease in maturity-onset diabetics.
November 1969, British medical journal,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
[Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
April 1981, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
September 1979, Diabete & metabolisme,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Insulin stimulating action of secretin in maturity onset diabetics.
March 1969, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
[When should stable maturity-onset diabetics be switched to insulin?].
October 1980, Schweizerische medizinische Wochenschrift,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Effect of weight reduction on the glucose tolerance in obese maturity onset diabetics.
January 1977, The Journal of the Egyptian Public Health Association,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Comparative study of sulfonylureas and biguanides on body weight of ketoacidosis-resistant maturity onset diabetics.
January 1971, Indian journal of medical sciences,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
[Behavior of the body weight in 2261 maturity-onset diabetics under conditions of ambulatory care].
June 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
M Viswanathan, and C Snehalatha, and A Ramachandran, and M Viswanathan
Immuno-reactive insulin in the serum of various groups of diabetics and non-diabetics.
August 1971, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!